Status:
RECRUITING
High Resolution Retinal Imaging
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
National Eye Institute (NEI)
Conditions:
Stargardts
Retinitis Pigmentosa
Eligibility:
All Genders
7+ years
Brief Summary
Studying the morphology and function of the normal and diseased retina in vivo is needed for advancing the detection, diagnosis, and treatment of retinal disease. This protocol uses an adaptive optics...
Eligibility Criteria
Inclusion
- Males or females age 7 years or older.
- Parental/guardian permission (informed consent) and if appropriate, child assent. Child subjects age 7-17 must give assent.
- Reasonable compliance with an imaging protocol as determined by the study personnel.
Exclusion
- Individuals that are at risk to acute glaucoma.
- Individuals that are photophobic and experience adverse psychological reactions to flashes of light.
- Ocular opacities, high refractive error, and high frequency of nystagmus as determined by the study team.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT01866371
Start Date
May 1 2013
End Date
December 1 2027
Last Update
April 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104